https://jamanetwork.com/journals/jama/fullarticle/2695647?guestAccessKey=b3c0e1a2-d206-4df0-8bce-2d938a392652
"These findings suggest inhibitors of VEGF-B–FLT-1 signaling or agonists of TGF-α–ErbB1 signaling may represent promising anti-inflammatory and neuroprotective therapies for MS and possibly other neurodegenerative diseases. Diets that promote anti-inflammatory pathways could be a noninvasive approach to treating brain inflammation"
Hampton T. Research Uncovers How Commensal Bacteria Contribute to Multiple Sclerosis. JAMA. 2018;320(5):429–430. doi:10.1001/jama.2017.12863
